The health status of people with diabetes in France

Diabetes is a major and growing public health burden. Its frequency has increased significantly over the past two decades. This concerns 3.3 million people in France and is expected to reach 592 million adults by 2035 worldwide. The French public health, health insurance, social security for the self-employed, the National Agency for the Safety of Medicinal Products and Health Products (ANSM) and the Higher Health Authority (HAS) are launching the 3rd edition of a national study on diabetes, designed to better know the state of health, quality of life, appeal to care and the cost of caring for people undergoing treatment for diabetes, and studying their evolution.

Introduction 3, 3rd edition of a single study among patients with diabetes

Conducted for the first time in 2001, and then renewed in 2007, Entred is the only study that can provide information at the epidemiological, medical, economic and social levels about people treated for diabetes in France.

This information is needed to develop preventive strategies that are needed to improve the health, medical practices and quality of life of people with diabetes. Entred meets the information needs of all health care providers working in the field of diabetes.

The importance and complexity of the questions to which he answers is reflected in the mobilization of many institutional partners.

In a sample of 13,000 randomly selected patients with diabetes who use drugs, the Entred 3 study is characterized dual approach patient-doctorHe also seeks to describe the changes that have taken place in the path of care, including accepted educational approaches, the use of nursing care and patient adherence to treatment.

Measure of evolution

This new national diabetes study will focus on long-term changes in the health status of people with diabetes, their quality of life, and the use of medical care. It will also look at recent developments in the field of disease management, such as the use of related facilities or healthcare applications.

An update to the Entred study is crucial to show progress made since 2007, as well as those that remain to be done, to better manage people with diabetes, prevent and delay the occurrence of serious complications (cardiac, ophthalmological, podiatric, renal …).

Describe the characteristics of people living with diabetes abroad and patients with type 1 diabetes

New fact Entred 3 will study the characteristics of certain populations.Thus, the focus will be on:

  • diabetics living in foreign departmentsKnowing that diabetes and its complications are almost twice as common as in metropolitan France.
  • adults with type 1 diabetesfor which little data is available today.

Results are expected from mid-2020.,

The main lessons of Entred Research:

  • Improved control of vascular risk factors (blood pressure, LDL cholesterol and glycemic control) in 2007 compared with 2001
  • Obesity increased compared with 2001 among people with type 2 diabetes (41% in 2007, +7 points)
  • Smoking is registered by more than one-third of young people with diabetes.
  • Quality of life is deteriorating mainly due to diabetes complications, which are still too common in 2007, despite the improved use of medical care.
  • Significant socioeconomic disparities in risk factors (obesity, smoking, poor glycemic control), and cardiovascular and podiatric complications
  • The average dependent burden for people with diabetes in 2007 is estimated at 660 euros, mainly for medicines, medical devices and dental care.
  • The cost of health care covered by health insurance increased by 80% (12.5 billion Euros in 2007 against 7.1 in 2001), mainly due to an increase in the number of people with diabetes and diabetes. intensified monitoring and treatment

To learn more

Http: /invs.santepubliquefrance.fr/Entred3